showed a trendP = 0.15
+2.2 kg, P < 0.05) and the Orlistat group also showed a trend for better glycemic control (HbA1c -0.1% vs. +0.2%, P = 0.15), but both sub-groups showed the same reversal of plasma cholesterols and plasma triglyceride towards pre-VLCD levels (data not shown).